Relaxing of regulations for regenerative medicines has cascading effect internationally, new research warns
Researchers warn that if just one country decides to relax regulations in the field, a heightened sense of competition can spur others to do the same.
It’s unclear whether this deregulation best serves competition, science or the patients.
Regenerative medicine focuses on developing therapies to regenerate or replace injured, diseased or defective cells, tissues or organs, like stem cell ‘treatments’.
Due to the use of living cells, it can be hard to set regulations in the same way as for other drugs so differences in the rules can occur.
But, according to Professor Margaret Sleeboom-Faulkner from the University of Sussex and Douglas Sipp, from the RIKEN Centre for Developmental Biology (CDB), Kobe, Japan, one thing that should always be maintained is efficacy – the ability to reliably produce a certain therapeutic result.
Professor of Social & Medical Anthropology, Margaret Sleeboom-Faulkner said: “Regenerative medicine contains a lot of economic promise, and there’s already been enormous investments into it.”
“While this is good in terms of focusing on new and innovative treatments to improve healthcare, it also leaves the field particularly vulnerable to regulatory brokerage. When one country relaxes their regulations, others are tempted to do the same in order to ‘keep up’.”
“Competition is the last way we want medicine to be progressing.”
The paper, published today in the journal Science, uses the example of South Korea as the first country to give preferential regulatory treatment to stem cell medicine. Their decision to issue a flurry of three stem cell-based medical products between 2011-12, and a fourth in 2014, attracted international scepticism for sacrificing clinical data standards in exchange for speed to market.
Yet Japan, who had launched a multi-billion dollar initiative to lead the world in regenerative medicine, began to see South Korea as a competitor. This resulted in a change of Japanese law in 2013, to allow regenerative medicine products a faster entry to the market.
Professor Sleeboom-Faulkner explained: “The International Society for Stem Cell Research has published general guidelines around regenerative medicines but countries regulate it in different ways.”
“At the moment, Britain has the safety net of the EU stamp on its regulations. While we’re not expecting to lose that, with Brexit looming we could see new interpretations of the existing guidelines and find ourselves starting to compete with other countries too.
“The UK has a reputation for high standards in medicine regulation and should continue to uphold this and be vigilant in the face of political pressures for eye-catching innovation.”
Professor Sleeboom-Faulkner also notes that strict regulations can have a negative impact too, making things hard for developing countries who have to import equipment and resources. As a result, strict regulations can cause some lower income countries to relax the implementation of their regulations and take measures to be able to catch up. Of late, however, it is the wealthy countries that have become more permissive.
Professor Sleeboom-Faulkner said: “What’s needed is a greater awareness that the regulations of one country can have cascading effects internationally.
“Regenerative medicines are often trialled on patients with a terminal illness, so it’s hard to know the precise effect of all of this. With less stringent clinical trials and the fast-tracking of ‘treatment’, we’d assume standards are slipping and risks increase, but it’s hard to prove that.”
“Ideally, regulations should be internationally coordinated and there should be a collaborative global approach in order to maintain basic standards.”
Professor Sleeboom-Faulkner is urging countries to be cautious when it comes to developing treatments particularly in the face of deviant ventures such as the recent case of gene-edited foetuses in China, and the current trend of increasing flexibilities in regulations internationally.
Learn more: Relaxing of regulations for regenerative medicines has cascading effect internationally, new research warns
The Latest on: Regenerative medicine regulation
[google_news title=”” keyword=”regenerative medicine regulation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regenerative medicine regulation
- Can sleep really clear toxins from the brain? New study offers clueson May 15, 2024 at 8:57 am
A new study in mice suggests the hypothesis that brain-cleansing occurs during sleep may be inaccurate. The findings show that mice cleaned more toxins and metabolites from the brain when they were ...
- Platelet Pathway More Traveled with Age, Leads to Excessive Clottingon May 14, 2024 at 5:17 pm
Researchers say findings may "profoundly impact the millions of elderly people at risk of experiencing adverse thrombotic events." ...
- Distinct population of ‘troublemaker’ platelet cells appear with aging, lead to blood clotting, diseaseon May 13, 2024 at 5:00 pm
Researchers have discovered a distinct, secondary population of platelets that appears with aging and have hyperreactive behavior and unique molecular properties, which could make them easier to ...
- Bitcoin Surges Post Jobs Report, Coinbase Reveals $1.2 Billion 1Q Net Profit, and More Crypto Newson May 3, 2024 at 8:26 am
Bitcoin rises in response to jobs data Bitcoin (COIN:BTCUSD) experiences a 4.5% increase on May 3, driven by US employment data. BTC/USD is trading at $61,751 at the time of writing. Specifically, non ...
- A new era of genetic and mechanistic molecular neuroscienceon May 2, 2024 at 1:25 am
Neuroscientists are increasingly viewing disorders of the brain through the lens of the underlying molecular mechanisms.
- Research breakthrough on birth defect affecting brain sizeon April 30, 2024 at 5:00 pm
A UC Riverside-led team has identified a molecular cellular mechanism that is linked to microencephaly, a condition in which a baby’s head is much smaller than expected.
- Scientists propose AI framework for mass-manufacturing of stem cells for regenerative medicineon April 4, 2024 at 8:03 am
They could be used for regenerative medicine and cell therapies to counteract ... Bioreactors provide a controlled environment through regulation of factors such as temperature, oxygen ...
- MSc Tissue Engineering for Regenerative Medicineon October 5, 2022 at 4:09 am
Prepare for PhD study, specialist clinical training or a career in related industries, including pharmaceutical, biotechnology and regenerative medicine sectors ... You can find regulations and ...
- About the Editorson November 24, 2021 at 6:02 am
She later investigated the role of epigenetic regulation in mammalian cell ... Blau's research area is regenerative medicine with a focus on stem cells. She is renowned for her work on nuclear ...
- Meet our academic staffon November 22, 2021 at 8:36 am
His group also has an ongoing interest in tissue engineering and regenerative medicine, and a long-term goal is to translate ... Her research interests include characterising regulation of epithelial ...
via Bing News